Table 3.
Spearman’s correlation to identify correlates between significant parameters
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CM CD8+ LFA-1 | ||||||||||||||
| 2 | Naïve CD4+ KLRG1 | ||||||||||||||
| 3 | Total CD8+ KLRG1 | .50 | |||||||||||||
| 4 | CM CD4+ BTLA4 | .55 | |||||||||||||
| 5 | CM CD4+ LFA-1 | .56 | |||||||||||||
| 6 | CD56dimCD16− NK CD2+ | ||||||||||||||
| 7 | CD56dimCD16− NK CD18+CD2+ | -.60 | |||||||||||||
| 8 | CD56dimCD16− NK CD18+CD11a− | -.47 | .49 | -.57 | |||||||||||
| 9 | CD56dimCD16− NK CD18+CD11c− | ||||||||||||||
| 10 | Total NK SLAM | .46 | -.53 | -.50 | |||||||||||
| 11 | Total CD8+ EMRA | -.44 | -.75 | ||||||||||||
| 12 | CD4+ KIR2DL5 | .48 | .75 | ||||||||||||
| 13 | KPS | -.43 | |||||||||||||
| 14 | Dr Bell’s Disability Scale | -.46 | .95 | ||||||||||||
Table 3 shows the significant correlation values between bivariate parameters for significant parameters for combined control, moderate CFS/ME and severe CFS/ME participant groups. All correlations shown have p < 0.01. CM: Central Memory, EMRA: CD45RA Effector Memory